Fieldpoint Private Securities’s BeOne Medicines Ltd ONC Stock Holding History

Fieldpoint Private Securities’s Portfolio ONC Stock Details ONC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$10K	Sell	60 -120	-67%	-$18.7K	﹤0.01%	745
2022 Q1	$34K	Sell	180 -259	-59%	-$55.1K	0.01%	692
2021 Q4	$119K	Buy	439 +30	+7%	+$10.1K	0.02%	412
2021 Q3	$148K	Hold	409	–	–	0.03%	354
2021 Q2	$129K	Buy	409 +5	+1%	+$1.66K	0.03%	371
2021 Q1	$141K	Sell	404 -99	-20%	-$32.8K	0.03%	341
2020 Q4	$130K	Buy	+503	New	+$138K	0.03%	355
2020 Q1	–	Sell	-1,486	Closed	-$246K	–	586
2019 Q4	$246K	Buy	1,486 +929	+167%	+$154K	0.07%	246
2019 Q3	$68K	Sell	557 -46	-8%	-$6.11K	0.02%	351
2019 Q2	$75K	Buy	+603	New	+$76.5K	0.02%	371

Other funds holding ONC

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

CII

Capital International Inc Los Angeles, California $14.3B AUM 34.19% 1-Year Est. Return

Fieldpoint Private Securities's ONC Position: Q2 2022 in Review

Fieldpoint Private Securities reduced its BeOne Medicines Ltd (ONC) stake by 67% in Q2 2022, selling an estimated $18.7K and leaving 60 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #745.

Fieldpoint Private Securities first reported a position in ONC in Q2 2019 and has held it in 10 quarters since. The position peaked at $246K in Q4 2019. 235 funds tracked by Wall St. Rank hold ONC as of Q2 2022.

Fieldpoint Private Securities held 60 shares of BeOne Medicines Ltd worth $10K as of Q2 2022.
Fieldpoint Private Securities sold 120 BeOne Medicines Ltd shares in Q2 2022, an estimated $18.7K.
BeOne Medicines Ltd made up ﹤0.01% of Fieldpoint Private Securities's portfolio in Q2 2022, its #745 holding.
Fieldpoint Private Securities first reported a position in BeOne Medicines Ltd in Q2 2019 and has held it in 10 quarters since.
Fieldpoint Private Securities's BeOne Medicines Ltd position peaked at $246K in Q4 2019.
235 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2022.

Based on Fieldpoint Private Securities's 13F filing for Q2 2022, filed 5 Aug 2022.